Organ preservation in rectal cancer – Challenges and future strategies

Neoadjuvant radiochemotherapy with subsequent total mesorectal excision is the standard of care for locally advanced rectal cancer. While this multimodal strategy has decreased local recurrences rates below 5%, long-term morbidities are considerable in terms of urinary, sexual or bowel functioning....

Descripción completa

Detalles Bibliográficos
Autores principales: Gani, C., Bonomo, P., Zwirner, K., Schroeder, C., Menegakis, A., Rödel, C., Zips, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893528/
https://www.ncbi.nlm.nih.gov/pubmed/29658007
http://dx.doi.org/10.1016/j.ctro.2017.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893528/
https://www.ncbi.nlm.nih.gov/pubmed/29658007
http://dx.doi.org/10.1016/j.ctro.2017.02.002

Ejemplares similares